This information was published on 2023-02-09T15:37:06 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2297395 (IR 1680814) |
| (220) |
01 Aug 2022
|
| (300) |
US, 28 Jul 2022, 97524034
|
| (511) (510) |
Class 5
Portable dry powder inhaler provided filled used for the administration to patients via oral inhalation of therapeutic or diagnostic agents in the form of dry powder aerosols for the treatment or prophylaxis of local lung and systemic diseases. Class 10 Portable dry powder inhaler provided empty used for the administration to patients via oral inhalation of therapeutic or diagnostic agents in the form of dry powder aerosols for the treatment or prophylaxis of local lung and systemic diseases, sold as a unit with the therapeutic or diagnostic agents in the form of dry powder aerosols. |
| (540) | AOS DPI |
| (550) | Word |
| (730) |
Respira Therapeutics, Inc.
|
| (750) |
Rouse Lawyers
|
Find out more about publications on the About page.